571 Results (Page 22 of 23)
UK Markets Research Reports
UK Sleep Disorders Market Analysis
This report presents a strategic analysis of the UK Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Sleep Disorders Market, offering unmatched value, accuracy and expert insights.
UK Vaccines Market Analysis
This report presents a strategic analysis of the UK Vaccines Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Vaccines Market, offering unmatched value, accuracy and expert insights.
UK Advanced Therapy Medicinal Products (ATMPs) Market Analysis
This report presents a strategic analysis of the UK Advanced Therapy Medicinal Products (ATMPs) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Advanced Therapy Medicinal Products (ATMPs) Market, offering unmatched value, accuracy and expert insights.
UK Graft-versus-Host Disease (GvHD) Therapeutics Market Analysis
The UK GvHD Therapeutics Market was valued at $65 Mn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030, to $98.38 Mn by 2030. The drivers of growth are growing prevalence, adoption of advanced technology, increasing awareness, and collaborations. The major players in this competition are Cadmon, Osiris, Shire, Allergan, Novartis, Merck, Pfizer, Sanofi, and Abbott among others.
UK Chronic Pain Therapeutics Market Analysis
The UK Chronic Pain Therapeutics Market is anticipated to experience a growth from $1.932 Bn in 2022 to $2.624 Bn by 2030, with a CAGR of 3.9% during the forecast period of 2022-2030. The main drivers of market growth include the imperative for cost-effective medicines to address the substantial financial burden on the NHS, rising demand for non-opioid treatments due to concerns over opioid risks, and the increasing prevalence of chronic pain linked to an aging population and the growing incidence of chronic diseases. The UK Chronic Pain Therapeutics Market encompasses various players across different segments, including Sanofi, Pfizer, Merck, Novartis, Bayer, Amgen, Abbott, AstraZeneca, Norgine, Xenova, etc., among various others.
UK Financial Assistance Programs Market Analysis
The UK Financial Assistance Programs Market was valued at $736.8 Mn in 2023 and is projected to grow at a CAGR of 12.6% from 2023 to 2023, to $1,690.0 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Takeda, AstraZeneca, Bristol Meyer Squibb, Roche, GSK, among others.
UK Blood Group Typing Market Analysis
The UK Blood Group Typing Market was valued at $89.44 Mn in 2023 and is predicted to grow at a CAGR of 7.70% from 2023 to 2030, to $150.33 Mn by 2030. The key drivers of this industry are rise in geriatric population, technological advancements, and government initiatives. The key players in the industry are Grifols S.A., Ortho Clinical Diagnostics, Merck KGaA, and Abbott Laboratories.
UK Periodontal Therapeutics Market Analysis
The UK Periodontal Therapeutics Market was valued at $22.7 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $32.4 Mn by 2030. The UK Periodontal Therapeutics Market is growing due to Rising prevalence of periodontitis, Emphasis on Preventive Oral Care, and Technological Developments. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
UK Cold Pain Therapy Market Analysis
The UK Cold Pain Therapy Market was valued at $57 Mn in 2022 and is predicted to grow at a CAGR of 3.2% from 2023 to 2030, to $74 Mn by 2030. The key drivers of this industry include the increasing prevalence of chronic pain disorders, technological advances in the industry, and demand for non-invasive pain relief approaches. The industry is primarily dominated by players such as DJO Global, Breg, Beiersdorf, Ossur, Performance Health, Pfizer, and Hisamitsu among others.
UK Radiology Service Market Analysis
The UK Radiology Service Market was valued at $104 Mn in 2023 and is predicted to grow at a CAGR of 12.7% from 2023 to 2030, to $240.2 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, rising demand for non-invasive procedures, and technological advancements. The prominent players of the UK Radiology Service Market are Chelsea and Westminister Hospital, St. Mary’s Hospital, St. George’s Hospital, The Royal London Hospital, Hammersmith Hospital, and Guy’s and St. Thomas’ Hospitals, among others.
UK MRI Market Analysis
The UK MRI Market was valued at $172.64 Mn in 2023 and is predicted to grow at a CAGR of 4.5% from 2023 to 2030, to $234.94 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, rise in healthcare expenditure, and increasing awareness for early and accurate diagnosis. The key players in the industry are GE Healthcare, Philips Healthcare, Siemens Healthineers, and Vista Health among others.
UK Chronic Cough Therapeutics Market Analysis
UK Chronic Cough Therapeutics Market was valued at $164 Mn in 2022 and is estimated to reach $263 Mn in 2030, exhibiting a CAGR of 6.1% during the forecast period. The key driver behind the growth of the chronic cough therapeutics market is the prevalent occurrence of chronic respiratory infections, often identified by persistent coughing. Leading participants in this market presently include GlaxoSmithKline, Pfizer, Reckitt Benckiser, Boots, Sanofi, AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis, and Teva Pharmaceutical Industries.
UK Hypersomnia Therapeutics Market Analysis
The UK Hypersomnia Therapeutics Market was valued at $3.70 Mn in 2023 and is predicted to grow at a CAGR of 4.70% from 2023 to 2030, to $5.10 Mn by 2030. The key drivers of this industry include increasing awareness, lifestyle changes, expanding geriatric population, and early detection. The key players in the industry are GSK, Hoffmann-La Roche Ltd, Sanofi, and Novartis among others.
UK Dental Implant Market Analysis
UK Dental Implant Market was valued at $2095.80 Mn in 2023 and is predicted to grow at a CAGR of 7.8% from 2023 to 2030, to $3545.50 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, a growing aging population, growing awareness of benefits, and improved dental technology. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
UK Head and Neck Cancer Therapeutics Market Analysis
The UK Head and Neck Cancer Therapeutics Market was valued at $1.96 Mn in 2023 and is predicted to grow at a CAGR of 12.70% from 2023 to 2030, to $4.53 Mn by 2030. The key drivers of this industry include growing cancer incidence, government initiatives, and technological innovations. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Roche, and Pfizer among others.
UK PET Scan Market Analysis
The UK PET Scan Market was valued at $50.4 Mn in 2023 and is predicted to grow at a CAGR of 3.4% from 2023 to 2030, to $63.7 Mn by 2030. The key drivers of the market include the rise in elderly population, increasing prevalence of chronic diseases, and increasing healthcare expenditure. The prominent players of the UK PET Scan Market are Siemens Healthineers, Toshiba, GE Healthcare, Hitachi, Canon Medical Systems, among others.
UK Genomic Diagnostics Market Analysis
UK Genomic Diagnostics Market was valued at $848.90 Mn in 2023 and is predicted to grow at a CAGR of 14.5% from 2023 to 2030, to $2,190.26 Mn by 2030. The key drivers of this industry include rising disease incidence, increased government support, and growing public awareness. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
UK Mouth Ulcer Therapeutics Market Analysis
The UK Mouth Ulcer Therapeutics Market was valued at $39.5 Mn in 2023 and is projected to grow at a CAGR of 1.9% from 2023 to 2023, to $45.1 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Bayer, MSD, Bristol-Myers Squibb Company, Colgate-Palmolive Company, GlaxoSmithKline PLC, Pfizer, Dr Reddy, Cipla, Pulse Pharmaceuticals among others.
UK Bio-implant Market Analysis
The UK Bio-implant Market was valued at $1690 Mn in 2023 and is predicted to grow at a CAGR of 3.9% from 2023 to 2030, to $2209 Mn by 2030. The UK Bio-implant Market is growing due to Patient Preference for Minimally Invasive Procedures, Rising Chronic Diseases, and Government Initiatives and Funding. The market is primarily dominated by players such as Smith & Nephew, Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Medtronic plc, Boston Scientific Corporation, and Johnson & Johnson Services.
UK Compression Therapy Market Analysis
UK Compression Therapy Market was valued at $99 Mn in 2022 and is estimated to reach $131 Mn in 2030, exhibiting a CAGR of 3.6% during the forecast period. The rising prevalence of venous conditions like leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a significant driver for the growth of the compression therapy market. Key players in this industry encompass entities such as Sigvaris, Medi, Juzo, Jobst, Bauerfeind, LymphoCare, Activa Healthcare, Amoena, Ofa Bamberg, and Variteks.
UK CT Scan Market Analysis
UK CT Scan Market was valued at $119.86 Mn in 2023 and is predicted to grow at a CAGR of 5.87% from 2023 to 2030, to $178.68 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, technological advancements in CT scanners, and the growing geriatric population. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
UK Lipid Disorder Therapeutics Market Analysis
The UK Lipid Disorder Therapeutics Market was valued at $16.2 Mn in 2023 and is predicted to grow at a CAGR of 12.83% from 2023 to 2030, to $37.8 Mn by 2030. UK Lipid Disorder Therapeutics Market is growing due to the Increasing Prevalence of Cardiovascular Diseases, Government & NHS Support, Technological Advancements, and Personalized Medicine. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
UK Mental Health Apps Market Analysis
The UK Mental Health Apps Market was valued at $161.2 Mn in 2023 and is predicted to grow at a CAGR of 13.2% from 2023 to 2030, to $383.96 Mn by 2030. The key drivers of this industry include reduced stigma, increasing smartphone penetration, and advancement in technology. The industry is primarily dominated by players such as Headspace, Calm, Happify, and Unmind among others.
UK Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The UK Cough Hypersensitivity Syndrome Therapeutics Market was valued at $211 Mn in 2022 and is predicted to grow at a CAGR of 3.9% from 2023 to 2030, to $286 Mn by 2030. The key drivers of this industry include the rising prevalence of Cough Hypersensitivity Syndrome, the evolving treatment landscape, and supportive regulatory policies. The industry is primarily dominated by players such as Johnson & Johnson, GSK, Merck, Novartis, AstraZeneca, and Pfizer among others.
UK Herbal Supplements Market Report
The UK Herbal Supplements Market was valued at $136.76 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $182.40 Mn by 2030. The key drivers of this industry include rising consumer preference, increased supplement consumption, and the prevalence of a sedentary lifestyle. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife, NOW Foods, Botanic Supplements, and Dabur among others.
